Brief: Ensysce Biosciences Provides Business Update And Reports Fourth Quarter And Full Year 2021 Financial Results
31/03/2022 21:27
March 31 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* ENSYSCE BIOSCIENCES INC - CASH AND CASH EQUIVALENTS WERE
$12.3
MILLION AS OF DECEMBER 31, 2021
* ENSYSCE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.45
Source text for Eikon: ID:nGNX13YPD7
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing